China Health Group Past Earnings Performance
Past criteria checks 0/6
China Health Group's earnings have been declining at an average annual rate of -8.4%, while the Healthcare industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 11.6% per year.
Key information
-8.4%
Earnings growth rate
-5.7%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 11.6% |
| Return on equity | -71.1% |
| Net Margin | -67.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns
Sep 05
Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation
Sep 11We Think China Health Group (HKG:673) Has A Fair Chunk Of Debt
Dec 01We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet
Sep 23We Think Some Shareholders May Hesitate To Increase China Health Group Limited's (HKG:673) CEO Compensation
Sep 02Did China Health Group Limited (HKG:673) Insiders Sell Shares?
Feb 16
Revenue & Expenses Breakdown
How China Health Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 60 | -40 | 50 | 0 |
| 31 Dec 23 | 67 | -35 | 47 | 0 |
| 30 Sep 23 | 74 | -29 | 43 | 0 |
| 30 Jun 23 | 75 | -36 | 42 | 0 |
| 31 Mar 23 | 76 | -42 | 40 | 0 |
| 31 Dec 22 | 87 | -38 | 42 | 0 |
| 30 Sep 22 | 97 | -35 | 44 | 0 |
| 30 Jun 22 | 102 | -23 | 42 | 0 |
| 31 Mar 22 | 107 | -12 | 40 | 0 |
| 31 Dec 21 | 102 | -11 | 39 | 0 |
| 30 Sep 21 | 96 | -9 | 37 | 0 |
| 30 Jun 21 | 92 | -8 | 38 | 0 |
| 31 Mar 21 | 88 | -8 | 38 | 0 |
| 31 Dec 20 | 73 | -23 | 42 | 0 |
| 30 Sep 20 | 58 | -38 | 45 | 0 |
| 30 Jun 20 | 51 | -37 | 44 | 0 |
| 31 Mar 20 | 45 | -37 | 43 | 0 |
| 31 Dec 19 | 46 | -29 | 38 | 0 |
| 30 Sep 19 | 47 | -22 | 32 | 0 |
| 30 Jun 19 | 40 | -22 | 35 | 0 |
| 31 Mar 19 | 32 | -23 | 38 | 0 |
| 31 Dec 18 | 25 | -24 | 39 | 0 |
| 30 Sep 18 | 17 | -25 | 41 | 0 |
| 30 Jun 18 | 21 | -32 | 44 | 0 |
| 31 Mar 18 | 24 | -39 | 47 | 0 |
| 31 Dec 17 | 26 | -41 | 56 | 0 |
| 30 Sep 17 | 27 | -43 | 64 | 0 |
| 30 Jun 17 | 21 | -56 | 73 | 0 |
| 31 Mar 17 | 15 | -69 | 83 | 0 |
| 31 Dec 16 | 8 | -81 | 81 | 0 |
| 30 Sep 16 | 1 | -94 | 79 | 0 |
| 30 Jun 16 | 12 | -83 | 69 | 0 |
| 31 Mar 16 | 24 | -73 | 60 | 0 |
| 31 Dec 15 | 32 | -55 | 52 | 0 |
| 30 Sep 15 | 40 | -38 | 44 | 0 |
| 30 Jun 15 | 39 | -47 | 38 | 0 |
| 31 Mar 15 | 38 | -56 | 32 | 0 |
| 31 Dec 14 | 37 | -77 | 37 | 0 |
| 30 Sep 14 | 36 | -98 | 43 | 0 |
| 30 Jun 14 | 37 | -83 | 45 | 0 |
| 31 Mar 14 | 38 | -68 | 46 | 0 |
| 31 Dec 13 | 36 | 58 | 50 | 0 |
Quality Earnings: 673 is currently unprofitable.
Growing Profit Margin: 673 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 673 is unprofitable, and losses have increased over the past 5 years at a rate of 8.4% per year.
Accelerating Growth: Unable to compare 673's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 673 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-14.3%).
Return on Equity
High ROE: 673 has a negative Return on Equity (-71.12%), as it is currently unprofitable.